Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms
BNS-P exhibited a dose-dependent antipsychotic effect in all clusters, particularly highlighting its efficacy in patients with predominant positive symptoms, even at lower doses. These findings provide novel and valuable insights for determining BNS-P dose tailoring to individual symptomatic characteristics in real-world practice.
Authors
- Yuji Matsumoto (ORCID: https://orcid.org/0000-0001-8901-2961)
- Yoshiteru Takekita (ORCID: https://orcid.org/0000-0003-2435-4033)
- Takahiro Masuda (ORCID: https://orcid.org/0000-0002-2225-6619)
- Masaki Kato (ORCID: https://orcid.org/0000-0001-6727-7272)
- Yosuke Koshikawa (ORCID: https://orcid.org/0000-0002-6736-092X)
- Kazumasa Yoshida (ORCID: https://orcid.org/0000-0002-0181-9857)
Institutions
- Kansai Medical University (JP)
- Sumitomo Dainippon Pharma (Japan) (JP)
Publication Details
- Journal
- Neuropsychopharmacology Reports
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1002/npr2.12490
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00